SOUTH SAN FRANCISCO, Calif. – Jan. 8, 2013 – Fluidigm Corporation (NASDAQ:FLDM) today announced its C1™ Single-Cell Auto Prep System has been selected as a recipient of a 2012 GOOD DESIGN™ Award administered by the Chicago Athenaeum: Museum of Architecture and Design and The European Centre for Architecture Art Design and Urban Studies.

Cell Signaling Technology Granted Patent for PCR Methods for Detection of a Subset of Treatable Non- Small Cell Lung Cancers

LEIDEN, December 17, 2012 - The BIOKÉ office will be closed from December 24th, 2012 until January 1st, 2013. We wish you Happy Holidays and a Good and Successful 2013!

Danvers, MA, December 5, 2012 – Cell Signaling Technology, Inc. (CST) of Danvers, MA is pleased to announce that NG-XMT™, CST’s patent-pending proteomics discovery platform can derive antigen-specific monoclonal antibodies from human serum....

State College, November 30, 2012 - SoftGenetics introduced a new version of the NextGENe software; NextGENe v2.3.1 has a new Copy Number Variation (CNV) analysis tool designed to make variant...

LEIDEN, October 5th, 2012 - BIOKÉ is one of main sponsors of the WAKZ run that will be organized on October 21st, 2012 in Leiden. The WAKZ run is one of the many activities organized by the Willem-Alexander Kinderfonds to ...

LEIDEN, October 3rd, 2012 - We are happy to announce the 4titude product selection tool. This tool allows you to find the compatible 4titude product for your equipment, plus all the information about the products.

Salt Lake City, August 16, 2012 - Effective as of August 10, 2012, Idaho Technology, Inc. changed its name to BioFire Diagnostics, Inc.  This change is in line with its innovative spirit and diagnostic focus. 

LEIDEN, June 28th, 2012 - The summer 2012 edition of the BIOKÉ newsletter, the BIOKÉ NEWS FLOW, has been published. This edition contains an interview, an application note about ChIPseq, and many more.

LEIDEN, June 26th, 2012 - On Thursday October 11th, 2012 the 3rd edition of the successful Cell Signaling Technology Symposium will be organized at the museum Naturalis in Leiden, the Netherlands.

SOUTH SAN FRANCISCO, Calif., and YOKOHAMA, Japan, June 13, 2012 - Revolutionary New System Provides Rapid Reliable Isolation and Processing of Individual Cells for Genomic Analysis.

LEIDEN, June 7th, 2012 - BIOKÉ, a Cell Signaling Technology Europe (CST Europe) company, and Advanced Cell Diagnostics, Inc. (ACD) announced that they have entered a distribution agreement. ACD supplies products for RNA in situ hybridization.

Danvers, MA, May 10, 2012 - Cell Signaling Technology, Inc. (CST) of Danvers, MA is pleased to announce the development of a new discovery platform for antigen-specific monoclonal antibodies.

Cambridge, May 9, 2012 - The Broad Institute of Harvard and MIT and microfluidics system maker Fluidigm Corp. of South San Francisco, Calif., have launched a new research center in Cambridge that is focused on mammalian single-cell genomics.

State College, March 27, 2012 - This newly released Genome News article cites the use of ChimerMarker and how it increases the quality and speed of pre and post BMT analysis. 

State College, February 22, 2012 - SoftGenetics has developed a new “step-wise” assembly technology for MiSeq data in NextGENe version 2.2.  The technology enables the software to continue the...

State College, February 15, 2012 - Have a look at this interesting application note: Mutation Detection and CNV Analysis for Illumina Sequencing data from HaloPlex Target Enrichment Panels using NextGENe Software for Clinical Research

Leiden, February 17, 2012 - BIOKÉ, a Cell Signaling Technology Europe company, announced that it has entered into an exclusive distribution agreement in the Benelux countries, effective March 1st, 2012, with SensoQuest.

State College, February 15, 2012 - 99.8 % Accuracy with Ion PGM™ PE reads and NextGENe software’s Floton™ Merge Tool.

SOUTH SAN FRANCISO, Calif., February 13, 2012 – Fluidigm Corporation announced the availability of the Access Array™ Barcode Library for the Ion Torrent Personal Genome Machine (PGM) sequencer.

SOUTH SAN FRANCISO, Calif., January 31, 2012 -This newly released paper demonstrates that using the Access Array System from Fluidigm with the Roche GS FLX saves time and money over Sanger sequencing.

South San Francisco, Calif. Oct. 3, 2011 - Fluidigm Corporation announced that China's Rujin Hospital in Shanghai has used the integrated fluidic circuits (IFCs) to help validate two new susceptibility loci for Graves' disease.

Leiden, May 16th, 2011 – Fluidigm Corporation (NASDAQ:FLDM) today introduced its 192.24 Dynamic Array™ IFC, designed to genotype 192 samples against 24 SNP assays in a single run, providing 4,608 data points in just one hour.

Leiden, May 24th, 2011 – In association with Science, Cell Signaling Technology will organize a webinar on post-translational modifications (phosphorylation, acetylation, ubiquitination) on Wednesday June 8, 2011.

Leiden, May 9th, 2011 – Fluidigm launches low-cost assays for gene expression, SNP genotyping and target-specific primers for Next-Generation Sequencing.

Leiden, May 9th, 2011 - Through NEB’s commitment to research and innovation, the Phusion products will now be manufactured at NEB and these products will also be available through BIOKÉ.

Leiden, March 1st 2011 - BIOKÉ, a Cell Signaling Technology (CST) Europe company, announced today that it has entered into an exclusive distribution agreement in the Benelux countries, effective April 1st, 2011, with New England Biolabs.

Leiden, October 25, 2010 - Roche and Fluidigm Corporation Enter Worldwide Co-Promotion Agreement for 454 Sequencing Systems and Access Array Platform.